104 related articles for article (PubMed ID: 3163416)
1. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
Patsner B; Mann WJ; Chalas E
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):949-50. PubMed ID: 3163416
[No Abstract] [Full Text] [Related]
2. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
O'Connell GJ; Ryan E; Murphy KJ; Prefontaine M
Obstet Gynecol; 1987 Dec; 70(6):930-2. PubMed ID: 3479735
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
Soper JT; Hunter VJ; Daly L; Tanner M; Creasman WT; Bast RC
Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
[TBL] [Abstract][Full Text] [Related]
4. Serum CA 125 levels in preoperative evaluation of pelvic masses.
Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
Chen DX; Schwartz PE; Li XG; Yang Z
Obstet Gynecol; 1988 Jul; 72(1):23-7. PubMed ID: 3164105
[TBL] [Abstract][Full Text] [Related]
6. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
[No Abstract] [Full Text] [Related]
7. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
[No Abstract] [Full Text] [Related]
8. Clinical relevance of the CA-125 assay for the management of patients with ovarian carcinoma.
Raju RN; Dalbow MH; Pugh RP; Concannon JP; Zidar BL; Zamerilla CF; Schenken LL
Prog Clin Biol Res; 1987; 248():289-97. PubMed ID: 3478733
[No Abstract] [Full Text] [Related]
9. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
10. [CA 125--a new characteristic in the diagnosis of ovarian carcinoma].
Tosner J
Cesk Gynekol; 1987 Jun; 52(5):381-5. PubMed ID: 3477330
[No Abstract] [Full Text] [Related]
11. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
Tosner J; Lacinová V; Louda B; Vanásek J
Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
[No Abstract] [Full Text] [Related]
12. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.
Malkasian GD; Knapp RC; Lavin PT; Zurawski VR; Podratz KC; Stanhope CR; Mortel R; Berek JS; Bast RC; Ritts RE
Am J Obstet Gynecol; 1988 Aug; 159(2):341-6. PubMed ID: 2457318
[TBL] [Abstract][Full Text] [Related]
13. Measurement of serum CA 125 in ovarian cancers.
Yuan CC; Ng HT; Yeh SH; Jeng FS; Chen SL; Tsai LC
Zhonghua Yi Xue Za Zhi (Taipei); 1987 Mar; 39(3):153-60. PubMed ID: 3484240
[No Abstract] [Full Text] [Related]
14. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
Koebl H; Tatra G; Bieglmayer C
Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of new three tumor markers for pancreatic carcinoma: CA19/9, CA 125 and DuPan 2].
Ohkura H; Sakawaki T
Gan No Rinsho; 1985 May; 31(6 Suppl):583-8. PubMed ID: 3861882
[TBL] [Abstract][Full Text] [Related]
17. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
[No Abstract] [Full Text] [Related]
18. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
[No Abstract] [Full Text] [Related]
19. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of CA 125 in preoperative diagnosis of patients with pelvic masses.
Finkler NJ
Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):105-7. PubMed ID: 8365503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]